Consequences of hyperoxia and the toxicity of oxygen in the lung

William J Mach, Amanda R Thimmesch, J Thomas Pierce, Janet D Pierce, William J Mach, Amanda R Thimmesch, J Thomas Pierce, Janet D Pierce

Abstract

Oxygen (O(2)) is life essential but as a drug has a maximum positive biological benefit and accompanying toxicity effects. Oxygen is therapeutic for treatment of hypoxemia and hypoxia associated with many pathological processes. Pathophysiological processes are associated with increased levels of hyperoxia-induced reactive O(2) species (ROS) which may readily react with surrounding biological tissues, damaging lipids, proteins, and nucleic acids. Protective antioxidant defenses can become overwhelmed with ROS leading to oxidative stress. Activated alveolar capillary endothelium is characterized by increased adhesiveness causing accumulation of cell populations such as neutrophils, which are a source of ROS. Increased levels of ROS cause hyperpermeability, coagulopathy, and collagen deposition as well as other irreversible changes occurring within the alveolar space. In hyperoxia, multiple signaling pathways determine the pulmonary cellular response: apoptosis, necrosis, or repair. Understanding the effects of O(2) administration is important to prevent inadvertent alveolar damage caused by hyperoxia in patients requiring supplemental oxygenation.

Figures

Figure 1
Figure 1
Reduction of oxygen. A single-electron transfer which converts molecular oxygen to the superoxide anion, creating an unstable molecule. The decomposition of hydrogen peroxide can be a source of the hydroxyl radical; this reaction requires both superoxide and hydrogen peroxide as precursors. These steps reduce oxygen to water by the addition of four electrons, yielding three reactive oxygen species: superoxide anion, hydrogen peroxide, and hydroxyl radical.

References

    1. Kim V, Benditt JO, Wise RA, Sharafkhaneh A. Oxygen therapy in chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society. 2008;5(4):513–518.
    1. Brokalaki H, Matziou V, Zyga S, et al. Omissions and errors during oxygen therapy of hospitalized patients in a large city of Greece. Intensive and Critical Care Nursing. 2004;20(6):352–357.
    1. Hickey S. An audit of oxygen therapy on a respiratory ward. British Journal of Nursing. 2007;16(18):1132–1136.
    1. Boyle M, Wong J. Prescribing oxygen therapy. An audit of oxygen prescribing practices on medical wards at north shore hospital, auckland, new zealand. New Zealand Medical Journal. 2006;119(1238, U2080)
    1. Shetty S, Padijnayayveetil J, Tucker T, Stankowska D, Idell S. The fibrinolytic system and the regulation of lung epithelial cell proteolysis, signaling, and cellular viability. American Journal of Physiology. 2008;295(6):L967–L975.
    1. Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Critical Care Medicine. 2003;31(4, supplement):S213–S220.
    1. Johnson LN, Koval M. Cross-talk between pulmonary injury, oxidant stress, and gap junctional communication. Antioxidants and Redox Signaling. 2009;11(2):355–367.
    1. Ciencewicki J, Trivedi S, Kleeberger SR. Oxidants and the pathogenesis of lung diseases. Journal of Allergy and Clinical Immunology. 2008;122(3):456–470.
    1. Clanton TL. Hypoxia-induced reactive oxygen species formation in skeletal muscle. Journal of Applied Physiology. 2007;102(6):2379–2388.
    1. Rahman I, Biswas SK, Kode A. Oxidant and antioxidant balance in the airways and airway diseases. European Journal of Pharmacology. 2006;533(1–3):222–239.
    1. Yee M, Vitiello PF, Roper JM, et al. Type II epithelial cells are critical target for hyperoxia-mediated impairment of postnatal lung development. American Journal of Physiology. 2006;291(5):L1101–L1111.
    1. Mason R, Broaddus C, Murray J. Murray & Nadel’s Textbook of Respiratory Medicine. (2nd edition) 2005;2
    1. Zhou H, Saidel GM, Cabrera ME. Multi-organ system model of O2 and CO2 transport during isocapnic and poikilocapnic hypoxia. Respiratory Physiology and Neurobiology. 2007;156(3):320–330.
    1. Dash RK, Bassingthwaighte JB. Simultaneous blood-tissue exchange of oxygen, carbon dioxide, bicarbonate, and hydrogen ion. Annals of Biomedical Engineering. 2006;34(7):1129–1148.
    1. Jones NL. An obsession with CO2 . Applied Physiology, Nutrition and Metabolism. 2008;33(4):641–650.
    1. Guyton AC, Hall JE. Textbook of Medical Physiology. 11th edition. Philadelphia, Pa, USA: Elsevier Saunders; 2006.
    1. Joiner J. NOAA Diving Manual: Diving for Science and Technology. 4th edition. Flagstaff, Ariz, USA: Best Publishing Company; 2001.
    1. Halliwell B. Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life. Plant Physiology. 2006;141(2):312–322.
    1. Hedley-Whyte J. Pulmonary oxygen toxicity: investigation and mentoring. Ulster Medical Journal. 2008;77(1):39–42.
    1. Allen BW, Demchenko IT, Piantadosi CA. Two faces of nitric oxide: implications for cellular mechanisms of oxygen toxicity. Journal of Applied Physiology. 2009;106(2):662–667.
    1. Kang KW, Lee SJ, Kim SG. Molecular mechanism of Nrf2 activation by oxidative stress. Antioxidants and Redox Signaling. 2005;7(11-12):1664–1673.
    1. Pagano A, Barazzone-Argiroffo C. Alveolar cell death in hyperoxia-induced lung injury. Annals of the New York Academy of Sciences. 2003;1010:405–416.
    1. Mantell LL, Horowitz S, Davis JM, Kazzaz JA. Hyperoxia-induced cell death in the lung—the correlation of apoptosis, necrosis, and inflammation. Annals of the New York Academy of Sciences. 1999;887:171–180.
    1. Crapo JD. Morphologic changes in pulmonary oxygen toxicity. Annual Review of Physiology. 1986;48:721–731.
    1. Crapo JD, Barry BE, Chang LY, Mercer RR. Alterations in lung structure caused by inhalation of oxidants. Journal of Toxicology and Environmental Health. 1984;13(2-3):301–321.
    1. Crapo JD, Tierney DF. Superoxide dismutase and pulmonary oxygen toxicity. American Journal of Physiology. 1974;226(6):1401–1407.
    1. Mensack SM, Murtaugh R. Oxygen toxicity. Compendium on Continuing Education for the Practicing Veterinarian. 1999;21(4):341–351.
    1. Romashko J, III, Horowitz S, Franek WR, et al. MAPK pathways mediate hyperoxia-induced oncotic cell death in lung epithelial cells. Free Radical Biology and Medicine. 2003;35(8):978–993.
    1. Kannan S, Pang H, Foster DC, Rao Z, Wu M. Human 8-oxoguanine DNA glycosylase increases resistance to hyperoxic cytotoxicity in lung epithelial cells and involvement with altered MAPK activity. Cell Death and Differentiation. 2006;13(2):311–323.
    1. Li LF, Liao SK, Ko YS, Lee CH, Quinn DA. Hyperoxia increases ventilator-induced lung injury via mitogen-activated protein kinases: a prospective, controlled animal experiment. Critical Care. 2007;11(1) Article ID R25.
    1. Papaiahgari S, Kleeberger SR, Cho HY, Kalvakolanu DV, Reddy SP. NADPH oxidase and ERK signaling regulates hyperoxia-induced Nrf2-ARE transcriptional response in pulmonary epithelial cells. Journal of Biological Chemistry. 2004;279(40):42302–42312.
    1. Qureshi ST, Zhang X, Aberg E, et al. Inducible activation of TLR4 confers resistance to hyperoxia-induced pulmonary apoptosis. Journal of Immunology. 2006;176(8):4950–4958.
    1. Mantell LL, Lee PJ. Signal transduction pathways in hyperoxia-induced lung cell death. Molecular Genetics and Metabolism. 2000;71(1-2):359–370.
    1. Zaher TE, Miller EJ, Morrow DM, Javdan M, Mantell LL. Hyperoxia-induced signal transduction pathways in pulmonary epithelial cells. Free Radical Biology and Medicine. 2007;42(7):897–908.
    1. Waxman AB, Kolliputi N. IL-6 protects against hyperoxia-induced mitochondrial damage via BCL-2 induced BAK interactions with mitofusions. American Journal of Respiratory Cell and Molecular Biology. 2009;41(4):385–396.
    1. Barlos D, Deitch EA, Watkins AC, et al. Trauma-hemorrhagic shock-induced pulmonary epithelial and endothelial cell injury utilizes different programmed cell death signaling pathways. American Journal of Physiology. 2009;296(3):L404–L417.
    1. Budinger GR, Sznajder JI. To live or die: a critical decision for the lung. Journal of Clinical Investigation. 2005;115(4):828–830.
    1. Kulkarni AC, Kuppusamy P, Parinandi N. Oxygen, the lead actor in the pathophysiologic drama: enactment of the trinity of normoxia, hypoxia, and hyperoxia in disease and therapy. Antioxidants and Redox Signaling. 2007;9(10):1717–1730.
    1. Min L, Jian-xing X. Detoxifying function of cytochrome c against oxygen toxicity. Mitochondrion. 2007;7(1-2):13–16.
    1. Czarna M, Jarmuszkiewicz W. Role of mitochondria in reactive oxygen species generation and removal; relevance to signaling and programmed cell death. Postepy Biochemii. 2006;52(2):145–156.
    1. Jezek P, Hlavata L. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. International Journal of Biochemistry and Cell Biology. 2005;37(12):2478–2503.
    1. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. International Journal of Biochemistry and Cell Biology. 2007;39(1):44–84.
    1. Tandon V, Gupta BM, Tandon R. Free radicals/reactive oxygen species. JK Practitioner. 2005;12(3):143–148.
    1. Apel K, Hirt H. Reactive oxygen species: metabolism, oxidative stress, and signal transduction. Annual Review of Plant Biology. 2004;55:373–399.
    1. Sakac V, Sakac M. Free oxygen radiacals and kidney diseases—part I. Medicinski Pregled. 2000;53(9-10):463–474.
    1. Cadenas E. Biochemistry of oxygen toxicity. Annual Review of Biochemistry. 1989;58:79–110.
    1. Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Radical Biology and Medicine. 2000;29(3-4):222–230.
    1. Comhair SA, Bhathena PR, Farver C, Thunnissen FB, Erzurum SC. Extracellular glutathione peroxidase induction in asthmatic lungs: evidence for redox regulation of expression in human airway epithelial cells. FASEB Journal. 2001;15(1):70–78.
    1. Davies KJ. Oxidative stress: the paradox of aerobic life. Biochemical Society Symposium. 1995;61:1–31.
    1. Kohen R, Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicologic Pathology. 2002;30(6):620–650.
    1. Pham-Huy LA, He H, Pham-Huy C. Free radicals, antioxidants in disease and health. International Journal of Biomedical Science. 2008;4(2):89–96.
    1. Nishikawa M, Inoue M. Oxidative stress and tissue injury. Japanese Journal of Anesthesiology. 2008;57(3):321–326.
    1. Chang R. Chemistry. 9th edition. Boston, Mass, USA: McGraw Hill; 2007.
    1. Droge W. Free radicals in the physiological control of cell function. Physiological Reviews. 2002;82(1):47–95.
    1. Hernandez-Saavedra D, McCord JM. Evolution and free radicals. Importance of oxidative stress in human pathology. Revista Medica del Instituto Mexicano del Seguro Social. 2007;45(5):477–484.
    1. Halliwell B, Aeschbach R, Loliger J, Aruoma OI. The characterization of antioxidants. Food and Chemical Toxicology. 1995;33(7):601–617.
    1. Halliwell B. How to characterize a biological antioxidant. Free Radical Research Communications. 1990;9(1):1–32.
    1. Buccellato LJ, Tso M, Akinci OI, Chandel NS, Budinger GR. Reactive oxygen species are required for hyperoxia-induced Bax activation and cell death in alveolar epithelial cells. Journal of Biological Chemistry. 2004;279(8):6753–6760.
    1. Bulger EM, Maier RV. Antioxidants in critical illness. Archives of Surgery. 2001;136(10):1201–1207.
    1. Yamaoka S, Kim HS, Ogihara T, et al. Severe vitamin E deficiency exacerbates acute hyperoxic lung injury associated with increased oxidative stress and inflammation. Free Radical Research. 2008;42(6):602–612.
    1. Noguchi N, Watanabe A, Shi H. Diverse functions of antioxidants. Free Radical Research. 2000;33(6):809–817.
    1. Tsan MF. Superoxide dismutase and pulmonary oxygen toxicity: lessons from transgenic and knockout mice (Review) International Journal of Molecular Medicine. 2001;7(1):13–19.
    1. van Raamsdonk JM, Hekimi S. Deletion of the mitochondrial superoxide dismutase sod-2 extends lifespan in caenorhabditis elegans. PLoS Genetics. 2009;5(2) Article ID e1000361.
    1. Auten RL, O’Reilly MA, Oury TD, Nozik-Grayck E, Whorton MH. Transgenic extracellular superoxide dismutase protects postnatal alveolar epithelial proliferation and development during hyperoxia. American Journal of Physiology. 2006;290(1):L32–L40.
    1. Bowler RP, Arcaroli J, Crapo JD, Ross A, Slot JW, Abraham E. Extracellular superoxide dismutase attenuates lung injury after hemorrhage. American Journal of Respiratory and Critical Care Medicine. 2001;164(2):290–294.
    1. Gao F, Kinnula VL, Myllarniemi M, Oury TD. Extracellular superoxide dismutase in pulmonary fibrosis. Antioxidants and Redox Signaling. 2008;10(2):343–354.
    1. Nozik-Grayck E, Suliman HB, Piantadosi CA. Extracellular superoxide dismutase. International Journal of Biochemistry and Cell Biology. 2005;37(12):2466–2471.
    1. Folz RJ, Abushamaa AM, Suliman HB. Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia. Journal of Clinical Investigation. 1999;103(7):1055–1066.
    1. O’Donovan DJ, Fernandes CJ. Mitochondrial glutathione and oxidative stress: implications for pulmonary oxygen toxicity in premature infants. Molecular Genetics and Metabolism. 2000;71(1-2):352–358.
    1. Smith AR, Visioli F, Hagen TM. Vitamin C matters: increased oxidative stress in cultured human aortic endothelial cells without supplemental ascorbic acid. FASEB Journal. 2002;16(9):1102–1104.
    1. Shi H, Liu KJ. Effects of glucose concentration on redox status in rat primary cortical neurons under hypoxia. Neuroscience Letters. 2006;410(1):57–61.
    1. Misra MK, Sarwat M, Bhakuni P, Tuteja R, Tuteja N. Oxidative stress and ischemic myocardial syndromes. Medical Science Monitor. 2009;15(10):RA209–RA219.
    1. Tkaczyk J, VIzek M. Oxidative stress in the lung tissue—sources of reactive oxygen species and antioxidant defence. Prague Medical Report. 2007;108(2):105–114.
    1. Ware LB. Pathophysiology of acute lung injury and the acute respiratory distress syndrome. Seminars in Respiratory and Critical Care Medicine. 2006;27(4):337–349.
    1. Frutos-Vivar F, Ferguson ND, Esteban A. Epidemiology of acute lung injury and acute respiratory distress syndrome. Seminars in Respiratory and Critical Care Medicine. 2006;27(4):327–336.
    1. Nagata K, Iwasaki Y, Yamada T, et al. Overexpression of manganese superoxide dismutase by N-acetylcysteine in hyperoxic lung injury. Respiratory Medicine. 2007;101(4):800–807.
    1. Manteiga Riestra E, Martinez Gonzalez O, Frutos Vivar F. Epidemiology of acute pulmonary injury and acute respiratory distress syndrome. Medicina Intensiva. 2006;30(4):151–161.
    1. Brock TG, Di Giulio C. Prolonged exposure to hyperoxia increases perivascular mast cells in rat lungs. Journal of Histochemistry and Cytochemistry. 2006;54(11):1239–1246.
    1. Wang L, Bastarache JA, Wickersham N, Fang X, Matthay MA, Ware LB. Novel role of the human alveolar epithelium in regulating intra-alveolar coagulation. American Journal of Respiratory Cell and Molecular Biology. 2007;36(4):497–503.
    1. Leikauf GD, McDowell SA, Bachurski CJ, et al. Functional genomics of oxidant-induced lung injury. Advances in Experimental Medicine and Biology. 2001;500:479–487.
    1. Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. American Journal of Physiology. 2008;295(3):L379–L399.
    1. Matthay MA, Zimmerman GA, Esmon C, et al. Future research directions in acute lung injury: summary of a national heart, lung, and blood institute working group. American Journal of Respiratory and Critical Care Medicine. 2003;167(7):1027–1035.
    1. Flores C, Ma SF, Maresso K, Ahmed O, Garcia JGN. Genomics of acute lung injury. Seminars in Respiratory and Critical Care Medicine. 2006;27(4):389–395.
    1. Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. New England Journal of Medicine. 2005;353(16):1685–1693.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere